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period studyA. Ikonomidis1,2, C. Venetis1, D. Georgantzis1, V. Giaslakiotis1,
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1) Biogonidiaki, Center of Infertility Investigation and Genetic Research, Volos,
Greece and 2) Democritus University of Thrace, Department of Microbiology,
Alexandroupolis, GreeceAbstractA total of 301 men and women attending local urologists and
gynaecologists in the state of Thessaly, central Greece, were
tested for Chlamydia trachomatis, Ureaplasma spp., Mycoplasma
genitalium and Mycoplasma hominis DNA. Investigation of the
tet(M) gene, which confers tetracycline resistance in these genera,
was also performed. Low incidence of C. trachomatis and
Mycoplasma spp. as well as high prevalence of Ureaplasma spp.,
especially among women, were found. The tet(M) gene was
absent in all cases, notably in a region where doxycycline
administration remains the ﬁrst therapeutic option unless special
medical conditions direct otherwise.
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p://dx.doi.org/10.1016/j.nmni.2015.11.005IntroductionChlamydia trachomatis, Ureaplasma spp. and Mycoplasma spp. (C-
U-M) are associated with urethritis, prostatitis, bacterial vagi-
nosis, cervicitis and pelvic inﬂammatory disease and are
considered to be sexually transmitted pathogens [1–3] that
might affect human fertility. Administration of doxycycline
(100 mg by mouth every 12 hours for 7 to 14 days, depending
on the site of infection) is a standard pharmaceutical treatment
for patients found to be positive for C-U-M [4]. However,
doxycycline efﬁcacy might be compromised by the tet(M)
determinant, a ribosome protection gene which is usually car-
ried on Tn1545-like conjugative chromosomal elements [5] and
causes tetracycline resistance in these genera [6].
In May 2015 we diagnosed in a 16-year-old female patient
Fitz-Hugh–Curtis syndrome that was attributed to Ureaplasma
urealyticum [7], which is nevertheless considered to constitute
normal urogenital ﬂora [8]. We thus decided to report on the
occurrence of C-U-M in central Greece because to date a
relatively large-scale study in Greek outpatients has not been
reported.Patients and MethodsFrom February 2012 until November 2015 a total of 301 men
and women attending local urologists and gynaecologists in
the state of Thessaly (which has more than 700 000 in-
habitants), Greece, were tested. The Biogonidiaki Center of
Infertility Investigation and Genetic Research, Volos, Greece
(which serves the broad region of the state of Thessaly),
performed C-U-M DNA investigation in semen and cervical
samples. Individuals who underwent C-U-M DNA testing
presented either with genital signs and symptoms of infection
(urethritis, prostatitis, cervicitis, leukocytes in semen analysis,
Papanicolaou test etc.) or with a history of infertility (at least
12 months of unprotected sexual intercourse without preg-
nancy). Many individuals underwent prenatal screening for C-
U-M. Duplicate samples were excluded, and all participants
were enrolled onto the study during their initial presentation.
All samples were investigated for C-U-M DNA using the
Amplisens (Bratislava, Slovak Republic) DNA-Sorb-AM
Nucleic Acid Extraction Kit as well as Amplisens
C. trachomatis/Ureaplasma/Mycoplasma genitalium–MULTI-
PRIME-FRT and Amplisens Mycoplasma hominis–FRT diag-
nostic CE-IVD PCR kits. The presence of a tet(M) determinant
was investigated using previously described primers and
ampliﬁcation conditions [9].European Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
NMNI Ikonomidis et al. C-U-M and tet(M) among outpatients in Central Greece 9ResultsA total of two participants (0.66%) were found to be positive
for C. trachomatis, 76 (25.25%) were positive for Ureaplasma
spp. and 11 (3.65%) were positive for M. hominis, while no
participant was found to be positive for M. genitalium. A total of
212 participants (70.43%) were negative for C-U-M DNA.
Among the 171 men tested, one (0.59%) was found to be
positive for C. trachomatis, 23 (13.45%) for Ureaplasma spp. and
six (3.51%) for M. hominis, while 141 (82.46%) were negative
for C-U-M DNA. Similarly, among the 130 women tested, one
(0.77%) was found to be positive for C. trachomatis, 53 (41.18%)
for Ureaplasma spp. and ﬁve (3.85%) for M. hominis, while 71
(54.62%) were negative for C-U-M DNA. It is worth
mentioning that Ureaplasma spp. was found to occur at a higher
rate in women than men (41.18% vs. 13.45%); most men (95,
55.56%) undergoing C-U-M testing presented with a history of
infertility, and most women (87, 66.92%) presented for prenatal
screening (Table 1). The tet(M) gene was not detected in either
case.DiscussionMichou et al. [10] reported different respective rates of C-U-M
prevalence among 87 women presenting with a history of
infertility (18.3% C. trachomatis, 16.1% U. urealyticum and 19.5%
M. hominis in PCR-tested cervical samples); their overall C-U-M
detection rate (44.8%) was higher than ours (29.86%). The
respective discrepancies could be partially attributable to the
different demographic groups studied as well as the fact that
occurrence of Ureaplasma parvum was not tested. Also, Al-
Sweih et al. [11] reported higher rates of C. trachomatis
(21.59%) andM. hominis (17.46%) positivity in men among those
studied in Kuwait, while Gdoura et al. [12] found C. trachomatis
and Mycoplasma spp. to prevail, at rates of 43.3% and 18.3%,
respectively, among Tunisian men. The prevalence ofTABLE 1. Accumulative data showing Chlamydia trachomatis, Urea
incidence relative to reason for outpatient presentation for C-U-M
Sample source Characteristic C. trachomatis Ureaplasm
Semen Genital signs/symptoms — 3
Infertility history 1 11
Prenatal screening — 9
Cervix Genital signs/symptoms — 5
Infertility history — 8
Prenatal screening 1 40
Total 2 76
C-U-M, Chlamydia trachomatis, Ureaplasma spp. and Mycoplasma spp.
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was similar to the previously mentioned studies.
Of note, in a region where doxycycline remains the ﬁrst
therapeutic option against C-U-M, no sample was found to be
positive for the tet(M) determinant. Also, in all C-U-M DNA–
positive cases, administration of doxycycline (100 mg by mouth
every 12 hours for 10 days) resulted in a negative repeated C-
U-M DNA test as well as remission of clinical signs and
symptoms of infection. A similar study in France demonstrated
an as yet relatively low incidence for the tet(M) gene among
Ureaplasma spp. (2.2%) but a higher rate of tet(M) occurrence
(18.75%) among M. hominis [13]. Also, a study from the United
States reported that 45 of 100 isolates of Ureaplasma spp. carry
the tet(M) gene [14]. With respect to chlamydiae, tetracycline
resistance is rare, and only a few reports have identiﬁed the
tetracycline resistance determinant tetC in the pig pathogen
Chlamydia suis [15]. Of note, previously described C. trachomatis
tetracycline-resistant clinical isolates [16] were eventually
shown to be phenotypically tetracycline sensitive [17].
In conclusion, we report what is to our knowledge the ﬁrst
large-scale study reporting on C-U-M occurrence among out-
patients in Greece. A technique of high speciﬁcity and sensi-
tivity was used using commercial CE-IVD PCR kits because
conventional microbiologic methods have been demonstrated
to inadequately detect C-U-M [10,18]. Our study found a low
incidence of C. trachomatis and Mycoplasma spp. in our region
and a higher prevalence of Ureaplasma spp., especially among
women. Unlike C. trachomatis, Ureaplasma and Mycoplasma
genera are considered to constitute normal urogenital ﬂora,
although Ureaplasma spp. have been described as a risk factor
for complications in pregnancy [8,19]. In addition, we recently
reported the second incidence of Fitz-Hugh–Curtis syndrome
worldwide that was attributed to U. urealyticum [7], while
10.11% of our PCR-conﬁrmed C-U-M-positive cases presented
with clinical manifestations (genital signs/symptoms) that
showed remission after doxycycline administration. In this
respect, physicians should be cautious when seeking microbi-
ologic evaluation of cervicovaginal or semen samples, in orderplasma spp., Mycoplasma genitalium and Mycoplasma hominis
testing
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Especially for women, menstrual tissue versus cervical sample
has been recently shown to increase the detection rate of C-U-
M in combination with PCR [10].AcknowledgementWe thank E. Fotiadou, laboratory technician at the Laboratory
of Microbiology, University Hospital of Alexandroupolis,
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